section name header

Notes

Immunization Schedule

  1. Tetanus and diphtheria toxoidsand acellular pertussis vaccine (Tdap). (Minimum age: 10 years for BOOSTRIX ® and 11 years for ADACEL ®)
    • Administer at age 11 or 12 years for those who have completed the recommended childhood DTP/DTaP vaccination series and have not received a tetanus and diphtheria toxoid (Td) booster dose.
    • Persons aged 13 through 18 years who have not received Tdap should receive a dose.
    • A 5-year interval from the last Td dose is encouraged when Tdap is used as a booster dose; however, a shorter interval may be used if pertussis immunity is needed.
  2. Human papillomavirus vaccine (HPV). (Minimum age: 9 years)
    • Administer the first dose to females at age 11 or 12 years.
    • Administer the second dose 2 months after the first dose and the third dose 6 months after the first dose (at least 24 weeks after the first dose).
    • Administer the series to females at age 13 through 18 years if not previously vaccinated.
  3. Meningococcal conjugate vaccine (MCV).
    • Administer at age 11 or 12 years, or at age 13 through 18 years if not previously vaccinated.
    • Administer to previously unvaccinated college freshmen living in a dormitory.
    • MCV is recommended for children aged 2 through 10 years with terminal complement component deficiency, anatomic or functional asplenia, and certain other groups at high-risk. See MMWR2005;54(No. RR-7).
    • Persons who received MPSV 5 or more years priviously and remain at increased risk for meningococcal disease should be revaccinated with MCV.
  4. Influenza vaccine.
    • Administer annually to children aged 6 months through 18 years.
    • For healthy nonpregnant persons (i.e., those who do not have underlying medical conditions that predispose them to influenza complications) aged 2 through 49 years, either LAIV or TIV may be used.
    • Administer 2 doses (separated by at least 4 weeks) to children aged younger than 9 years who are receiving influenza vaccine for the first time or who was vaccinated for the first time during the previous influenza season but only received 1 dose.
  5. Pneumococcal polysaccharide vaccine (PPSV).
    • Administer to children with certain underlying medical conditions (see MMWR1997;46[No. RR-8]), including a cochlear implant. A single revaccination should be administered to children with functional or anatomic asplenia or other immunocompromising condition after 5 years.
  6. Hepatitis A vaccine (HepA).
    • Administer 2 doses at least 6 months apart.
    • HepA is recommended for children older than 1 year who live in areas where vaccination programs target older children or who are at increased risk of infection. See MMWR2006;55(No. RR-7).
  7. Hepatitis B vaccine (HepB).
    • Administer the 3-dose series to those not previously vaccinated.
    • A 2-dose series (separated by at least 4 months) of adult formulation Recombivax HB ® is licensed for children aged 11 through 15 years.
  8. Inactivated poliovirus vaccine (IPV).
    • For children who received an all-IPV or all-oral poliovirus (OPV) series, a fourth dose is not necessary if the third dose was administered at age 4 years or older.
    • If both OPV and IPV were administered as part of a series, a total of 4 doses should be administered, regardless of the child’s current age.
  9. Measles, mumps, and rubella vaccine (MMR).
    • If not previously vaccinated, administer 2 doses or the second dose for those who have received only 1 dose, with at least 28 days between doses.
  10. Varicella vaccine.
    • For persons aged 7 through 18 years without evidence of immunity (see MMWR2007;56[No. RR-4]), administer 2 doses if not previously vaccinated or the second dose if they have received only 1 dose.
    • For persons aged 7 through 12 years, the minimum interval between doses is 3 months. However, if the second dose was administered at least 28 days after the first dose, it can be accepted as valid.
    • For persons aged 13 years and older, the minimum interval between doses is 28 days.

The Recommended Immunization Schedules for Persons Aged 0 Through 18 Years are approved by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/recs/acip), the American Academy of Pediatrics (http://www.aap.org), and the American Academy of Family Physicians (http://www.aafp.org).

DEPARTMENT OF HEALTH AND HUMAN SERVICES · CENTERS FOR DISEASE CONTROL AND PREVENTION

Immunization Schedule